On Tuesday, iBio Inc (NASDAQ: IBIO) opened higher 8.59% from the last session, before settling in for the closing price of $1.28. Price fluctuations for IBIO have ranged from $0.56 to $6.89 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 64.37%. Company’s average yearly earnings per share was noted 85.33% at the time writing. With a float of $19.12 million, this company’s outstanding shares have now reached $19.35 million.
iBio Inc (IBIO) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of iBio Inc is 5.61%, while institutional ownership is 15.86%. The most recent insider transaction that took place on Jan 10 ’25, was worth 25,000. In this transaction Chief Financial Officer of this company bought 9,191 shares at a rate of $2.72, taking the stock ownership to the 11,139 shares. Before that another transaction happened on Jan 10 ’25, when Company’s insider bought 9,191 for $2.72, making the entire transaction worth $25,000. This insider now owns 18,316 shares in total.
iBio Inc (IBIO) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.46 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.46) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 85.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 43.54% during the next five years compared to 64.37% growth over the previous five years of trading.
iBio Inc (NASDAQ: IBIO) Trading Performance Indicators
Check out the current performance indicators for iBio Inc (IBIO). In the past quarter, the stock posted a quick ratio of 1.59. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 70.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.75, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of iBio Inc (IBIO)
The latest stats from [iBio Inc, IBIO] show that its last 5-days average volume of 13.31 million was superior to 1.95 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 53.46%.
During the past 100 days, iBio Inc’s (IBIO) raw stochastic average was set at 71.64%, which indicates a significant increase from 64.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1750 in the past 14 days, which was higher than the 0.0808 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8882, while its 200-day Moving Average is $1.7691. Now, the first resistance to watch is $1.4900. This is followed by the second major resistance level at $1.5900. The third major resistance level sits at $1.7150. If the price goes on to break the first support level at $1.2650, it is likely to go to the next support level at $1.1400. Assuming the price breaks the second support level, the third support level stands at $1.0400.
iBio Inc (NASDAQ: IBIO) Key Stats
There are currently 20,255K shares outstanding in the company with a market cap of 28.15 million. Presently, the company’s annual sales total 400 K according to its annual income of -18,380 K. Last quarter, the company’s sales amounted to 200 K and its income totaled -5,160 K.
